Las Cruces, NM – [Date] – Palladium Diagnostics LLC, a leading provider of rapid diagnostic solutions is excited to announce the appointment of Daniel Levenson as Vice President of
Business Development. This strategic addition to the team will further solidify Palladium
Diagnostics’ position as a premier provider of end-to-end integrated services for complete point- of-use IVD devices.
In his new role, Mr. Levenson will leverage his extensive industry network and expertise to forge
strategic partnerships with leading companies in the diagnostics industry. He will also drive the
development of new CLIA lab services, including protein purification and assay validation, and
promote Palladium Diagnostics’ existing assay development services.
Mr. Levenson brings a wealth of experience and a proven track record of success in the
diagnostics industry. As the former CEO of Millenia Diagnostics, he led the company’s growth
and development, overseeing the development and commercialization of numerous diagnostic
assays. In addition, he held key scientific roles at BD, Cue Health, and CTK Biotech, where he
contributed to the development of innovative diagnostic solutions, including COVID-19 tests,
influenza assays, and molecular diagnostics on both multiplex lateral flow assays and nucleic
amplification microfluidic devices.
A highlight of Mr. Levenson’s career is his pivotal role in securing funding from the NIH’s RADx
initiative to develop a rapid COVID-19 antigen test. This achievement demonstrates his ability to
identify critical market needs and translate them into innovative solutions.
“We are thrilled to welcome Daniel to the Palladium Diagnostics team,” said Jeff Bauer, CEO of
Palladium Diagnostics. “His extensive experience, leadership skills, and passion for innovation
align perfectly with our vision. We are confident that his contributions will drive significant growth and success for the company.”
To learn more about how Palladium Diagnostics can partner with your organization, please
contact Daniel Levenson at [Email Address] or [Phone Number].
About Palladium Diagnostics
Palladium Diagnostics is a cutting-edge company focused on developing and commercializing
innovative rapid diagnostic tests. Our mission is to provide accurate, affordable, and accessible
solutions to healthcare providers and consumers worldwide.
Made it to Chicago for ADLM 2024! Palladium DX is at Booth 1257, and we will be happy to discuss your needs for:
Rapid assay development
Clinical trials and regulatory support
Materials identification and supply
Assay validation and verification services
CLIA certified Highly Complex lab to support development and trials
Looking forward to meeting you soon.
Just over one month ago, Dr Kevin Jones our CTO took part in a webinar sponsored by Porex presenting on Porous plastics and how they enable the use of new samples types and more accurate assays.
Many of you have been asking for copies of the presentation, so here is the link to the full webinar on the Genome Web site.
https://lnkd.in/gAGUm6EA